These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33529134)

  • 1. Relevance of Spontaneous Portosystemic Shunts Detected with CT in Patients with Cirrhosis.
    Nardelli S; Riggio O; Turco L; Gioia S; Puzzono M; Bianchini M; Ridola L; Aprile F; Gitto S; Pelle G; Di Martino M; Marzocchi G; Caporali C; Spagnoli A; Di Rocco A; Schepis F
    Radiology; 2021 Apr; 299(1):133-140. PubMed ID: 33529134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of transjugular intrahepatic portosystemic shunt for treatment of variceal bleeding in patients with cirrhosis with or without spontaneous portosystemic shunt.
    Leng X; Zhang F; Zhang M; Guo H; Yin X; Xiao J; Wang Y; Zou X; Zhuge Y
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):853-858. PubMed ID: 30633039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis.
    He C; Lv Y; Wang Z; Guo W; Tie J; Li K; Niu J; Zuo L; Yu T; Yuan X; Chen H; Wang Q; Liu H; Bai W; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Wang J; Yin Z; Fan D; Han G
    Dig Liver Dis; 2018 Dec; 50(12):1315-1323. PubMed ID: 29960900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.
    Praktiknjo M; Simón-Talero M; Römer J; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Maurer MH; Zipprich A; Triolo M; Maleux G; Fialla AD; Dam C; Vidal-González J; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; López M; Jansen C; Chang J; Schierwagen R; Uschner F; Kukuk G; Meyer C; Thomas D; Wolter K; Strassburg CP; Laleman W; La Mura V; Ripoll C; Berzigotti A; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Krag A; Genescà J; Trebicka J;
    J Hepatol; 2020 Jun; 72(6):1140-1150. PubMed ID: 31954206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of patients with liver cirrhosis and spontaneous portosystemic shunts detected by ultrasound in a tertiary care and transplantation centre.
    Lipinski M; Saborowski M; Heidrich B; Attia D; Kasten P; Manns MP; Gebel M; Potthoff A
    Scand J Gastroenterol; 2018 Sep; 53(9):1107-1113. PubMed ID: 30270689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Large, Spontaneous Portosystemic Shunts in Liver Transplantation: Case Report and Review of Literature.
    Miranda PB; Artacho GS; Bellido CB; Marín Gómez LM; Franco CC; Álamo Martinez JM; Padillo Ruiz FJ; Gómez Bravo MÁ
    Transplant Proc; 2020 Mar; 52(2):566-568. PubMed ID: 32057499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early, late, or no shunt embolization in patients with cirrhosis- and portosystemic shunt-related hepatic encephalopathy.
    Philips CA; Rajesh S; George T; Ahamed R; Mohanan M; Augustine P
    Indian J Gastroenterol; 2020 Aug; 39(4):377-387. PubMed ID: 32929684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful control of portal hypertension-related complications after two embolization procedures for multiple and large spontaneous portosystemic shunts in a patient with liver cirrhosis.
    Ueno W; Sato N; Miura K; Morimoto N; Watanabe S; Nomoto H; Isoda N; Kijima S; Kikuchi T; Manaka S; Mori H; Yamamoto H
    Clin J Gastroenterol; 2021 Aug; 14(4):1227-1232. PubMed ID: 33993428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
    Simón-Talero M; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Praktiknjo M; Maurer MH; Zipprich A; Triolo M; Vangrinsven G; Garcia-Martinez R; Dam A; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; Lopez M; Kukuk G; Krag A; Bañares R; Laleman W; La Mura V; Ripoll C; Berzigotti A; Trebicka J; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Augustin S; Genescà J;
    Gastroenterology; 2018 May; 154(6):1694-1705.e4. PubMed ID: 29360462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embolization of splenorenal shunt associated to portal vein thrombosis and hepatic encephalopathy.
    Franzoni Lde C; de Carvalho FC; Garzon RG; Yamashiro Fda S; Augusti L; Santos LA; Dorna Mde S; Baima JP; Lima TB; Caramori CA; Silva GF; Romeiro FG
    World J Gastroenterol; 2014 Nov; 20(42):15910-5. PubMed ID: 25400477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shunt occlusion for portosystemic shunt syndrome related refractory hepatic encephalopathy-A single-center experience in 21 patients from Kerala.
    Philips CA; Kumar L; Augustine P
    Indian J Gastroenterol; 2017 Sep; 36(5):411-419. PubMed ID: 29124669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portosystemic shunts in children: a 15-year experience.
    Botha JF; Campos BD; Grant WJ; Horslen SP; Sudan DL; Shaw BW; Langnas AN
    J Am Coll Surg; 2004 Aug; 199(2):179-85. PubMed ID: 15275870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
    Luo J; Li M; Zhang Y; Wang H; Huang M; Li Z; Chen J; Wu C; Qian J; Guan S; Jiang Z
    Eur Radiol; 2018 Sep; 28(9):3661-3668. PubMed ID: 29600476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
    Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
    J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of spontaneous splenorenal shunt on liver volume and long-term survival of liver cirrhosis.
    Yi F; Guo X; Wang L; Xu X; An Y; Tang Y; Zhang W; Tacke F; Arora A; Qi X
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1694-1702. PubMed ID: 33393106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver atrophy and regeneration in noncirrhotic portal vein thrombosis: Effect of surgical shunts.
    Elnaggar AS; Griesemer AD; Bentley-Hibbert S; Brown RS; Martinez M; Lobritto SJ; Kato T; Emond JC
    Liver Transpl; 2018 Jul; 24(7):881-887. PubMed ID: 29377486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.
    Jalan R; Elton RA; Redhead DN; Finlayson ND; Hayes PC
    J Hepatol; 1995 Aug; 23(2):123-8. PubMed ID: 7499782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postshunt hepatic encephalopathy in liver transplant recipients.
    Braun MM; Bar-Nathan N; Shaharabani E; Aizner S; Tur-Kaspa R; Belenky A; Mor E; Ben-Ari ZZ
    Transplantation; 2009 Mar; 87(5):734-9. PubMed ID: 19295319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Indications and Long-Term Outcomes of Surgical Portosystemic Shunts in Adults.
    Sen I; Yohanathan L; Kärkkäinen JM; Nagorney DM
    J Gastrointest Surg; 2021 Jun; 25(6):1437-1444. PubMed ID: 32424687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous portosystemic shunts in liver cirrhosis: new approaches to an old problem.
    Vidal-González J; Quiroga S; Simón-Talero M; Genescà J
    Therap Adv Gastroenterol; 2020; 13():1756284820961287. PubMed ID: 33062057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.